Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0115008003
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Pre Market | 02434636 | JAMP PHARMA CORPORATION | ALPRAZOLAM | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 1 MG |
Marketed | 02243611 | APOTEX INC | APO-ALPRAZ | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 1 MG |
Approved | 02397056 | JAMP PHARMA CORPORATION | JAMP ALPRAZOLAM | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 1 MG |
Cancelled Post Market | 02400146 | JAMP PHARMA CORPORATION | JAMP-ALPRAZOLAM | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 1 MG |
Cancelled Post Market | 02229813 | MYLAN PHARMACEUTICALS ULC | MYLAN-ALPRAZOLAM | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 1 MG |
Cancelled Post Market | 02417650 | NATCO PHARMA (CANADA) INC | NAT-ALPRAZOLAM | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 1 MG |
Marketed | 02248706 | PRO DOC LIMITEE | PRO-ALPRAZOLAM | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 1 MG |
Cancelled Post Market | 02404893 | LABORATOIRE RIVA INC. | RIVA-ALPRAZOLAM | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 1 MG |
Marketed | 00723770 | BGP PHARMA ULC | XANAX | Human | Yes | Targeted (CDSA IV) | 1 | ALPRAZOLAM | 1 MG |
Application information
Related information
Contact us
Version 4.0.3